Cardiogenics Holdings Stock Today
| CGNH Stock | USD 0.0001 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressVery High
|
CardioGenics Holdings is trading at 1.0E-4 as of the 27th of March 2025. This is a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. CardioGenics Holdings has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 27th of December 2024 and ending today, the 27th of March 2025. Click here to learn more.
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Mississauga, Canada. The company has 96.05 M outstanding shares. More on CardioGenics Holdings
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CardioGenics Pink Sheet Highlights
| CEO, Director | Yahia Gawad |
| Business Concentration | Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) |
CardioGenics Holdings [CGNH] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.92 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CardioGenics Holdings's market, we take the total number of its shares issued and multiply it by CardioGenics Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CardioGenics Holdings conducts business under Biotechnology sector and is part of Health Care industry. The entity has 96.05 M outstanding shares.
CardioGenics Holdings currently holds about 96.81 K in cash with (606.64 K) of positive cash flow from operations.
Check CardioGenics Holdings Probability Of Bankruptcy
Ownership AllocationCardioGenics Holdings holds a total of 96.05 Million outstanding shares. Almost 97.49 percent of CardioGenics Holdings outstanding shares are held by general public with 2.52 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CardioGenics Ownership Details
CardioGenics Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CardioGenics Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Other Information on Investing in CardioGenics Pink Sheet
CardioGenics Holdings financial ratios help investors to determine whether CardioGenics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CardioGenics with respect to the benefits of owning CardioGenics Holdings security.